Literature DB >> 22503947

Effects of HMG on revascularization and follicular survival in heterotopic autotransplants of mouse ovarian tissue.

Yanrong Wang1, Qing Chang, Jing Sun, Ling Dang, Wenzhi Ma, Changchun Hei, Xinsheng Shen, Chengjun Zhao, Yufang Cai, Xiuying Pei, Xiaoguang Zhang, Yin Wang, Xiaohua Jiang.   

Abstract

Ovarian tissue transplantation is now considered as a procedure to preserve the fertility of young women patients undergoing cancer therapy. The present study investigated the effects and mechanism of human menopausal gonadotrophin (HMG) intervention on vascular remoulding in ovarian heterotopic autotransplantation. Ovaries of 8-week-old mice were cultured in vitro with different concentrations of HMG for 3h for measuring the expression of vascular endothelial growth factor (VEGF). The cultured ovaries were implanted under the kidney capsule and removed 24, 36, 48 h or 1 month after transplantation. Revascularization, fluid exudation and the number of surviving ovarian follicles were observed. The results showed that VEGF was increased 1.6-6.5 times in the HMG intervention groups. Revascularization appeared 24-36 h after transplantation and was earlier than that of the control. Fluid exudation increased incrementally with increasing HMG concentrations. The total number of surviving ovarian follicles was increased by 1.2-1.5 times in the HMG 0.15 IU/ml group as compared with the other groups 1 month after transplantation. It is concluded that intervention with HMG in vitro before transplantation could improve the blood supply reconstruction and survival of the autotransplanted ovarian follicles, which might be associated with increased VEGF expression.
Copyright © 2012 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503947     DOI: 10.1016/j.rbmo.2012.02.025

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  11 in total

1.  Ovarian transplantation with robotic surgery and a neovascularizing human extracellular matrix scaffold: a case series in comparison to meta-analytic data.

Authors:  Kutluk Oktay; Loris Marin; Giuliano Bedoschi; Fernanda Pacheco; Yodo Sugishita; Tai Kawahara; Enes Taylan; Carlo Acosta; Heejung Bang
Journal:  Fertil Steril       Date:  2021-11-17       Impact factor: 7.329

Review 2.  Delaying Reproductive Aging by Ovarian Tissue Cryopreservation and Transplantation: Is it Prime Time?

Authors:  Kutluk H Oktay; Loris Marin; Boris Petrikovsky; Michael Terrani; Samir N Babayev
Journal:  Trends Mol Med       Date:  2021-02-04       Impact factor: 15.272

3.  Isoform 165 of vascular endothelial growth factor in collagen matrix improves ovine cryopreserved ovarian tissue revascularisation after xenotransplantation in mice.

Authors:  Laurie Henry; Soraya Labied; Maïté Fransolet; Nathalie Kirschvink; Silvia Blacher; Agnès Noel; Jean-Michel Foidart; Michelle Nisolle; Carine Munaut
Journal:  Reprod Biol Endocrinol       Date:  2015-03-07       Impact factor: 5.211

4.  Does adipose tissue-derived stem cell therapy improve graft quality in freshly grafted ovaries?

Authors:  Luciana L Damous; Juliana S Nakamuta; Ana E T Saturi de Carvalho; Katia Candido Carvalho; José Maria Soares; Manuel de Jesus Simões; José Eduardo Krieger; Edmund Chada Baracat
Journal:  Reprod Biol Endocrinol       Date:  2015-09-23       Impact factor: 5.211

5.  Meloxicam and buprenorphine treatment after ovarian transplantation does not affect estrous cyclicity and follicular integrity in aged CBA/J mice.

Authors:  Anna H Le; Luis A Bonachea; Shelley L Cargill
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

6.  Optimal FSH usage in revascularization of allotransplanted ovarian tissue in mice.

Authors:  Wen-Zhi Ma; Xiao-Min Zheng; Chang-Chun Hei; Cheng-Jun Zhao; Sha-Sha Xie; Qing Chang; Yu-Fang Cai; Hua Jia; Xiu-Ying Pei; Yan-Rong Wang
Journal:  J Ovarian Res       Date:  2017-01-17       Impact factor: 4.234

7.  Effect of treatment with angiopoietin-2 and vascular endothelial growth factor on the quality of xenografted bovine ovarian tissue in mice.

Authors:  Hyun Sun Kong; Jaewang Lee; Hye Won Youm; Seul Ki Kim; Jung Ryeol Lee; Chang Suk Suh; Seok Hyun Kim
Journal:  PLoS One       Date:  2017-09-15       Impact factor: 3.240

8.  Spontaneous antral follicle formation and metaphase II oocyte from a non-stimulated prepubertal ovarian tissue xenotransplant.

Authors:  Laura Lotz; Jana Liebenthron; Stephanie M Nichols-Burns; Markus Montag; Inge Hoffmann; Matthias W Beckmann; Hans van der Ven; Dagmar Töpfer; Ralf Dittrich
Journal:  Reprod Biol Endocrinol       Date:  2014-05-15       Impact factor: 5.211

9.  The Increased Expression of Connexin and VEGF in Mouse Ovarian Tissue Vitrification by Follicle Stimulating Hormone.

Authors:  Yanzhou Yang; Jie Chen; Hao Wu; Xiuying Pei; Qing Chang; Wenzhi Ma; Huiming Ma; Changchun Hei; Xiaomin Zheng; Yufang Cai; Chengjun Zhao; Jia Yu; Yanrong Wang
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

10.  Repetitive Maturation of Oocytes From Non-Stimulated Xenografted Ovarian Tissue From a Prepubertal Patient Indicating the Independence of Human Ovarian Tissue.

Authors:  Nathalie Raffel; Laura Lotz; Inge Hoffmann; Jana Liebenthron; Stephan Söder; Matthias W Beckmann; Ralf Dittrich
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-12-18       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.